e-learning
resources
Virtual 2021
07.09.2021
Respiratory infections and bronchiectasis outcomes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serum heparan sulfate levels predict the etiology of acute exacerbations in COPD
E. Papakonstantinou (Basel, Switzerland), M. Karakioulaki (Basel, Switzerland), L. Grize (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
Source:
Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Session:
Respiratory infections and bronchiectasis outcomes
Session type:
Oral Presentation
Number:
2858
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Papakonstantinou (Basel, Switzerland), M. Karakioulaki (Basel, Switzerland), L. Grize (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland). Serum heparan sulfate levels predict the etiology of acute exacerbations in COPD. 2858
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Serum magnesium levels in acute exacerbation of COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007
Predictors for significant changes in serum sulfated glycosaminoglycans at COPD exacerbations
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Serum magnesium levels of patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 107s
Year: 2003
Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009
Chronic bronchitis and plasma markers of inflammation predict incidence of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 681s
Year: 2007
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Study on the relation between serum complement (C3, C4) levels and acute exacerbations in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Efficiency of nebulised magnesium sulphate in exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 214s
Year: 2006
Serum lysophosphatidic acid levels and exacerbation frequency in chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020
The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Diaphragm dysfunction in chronic obstructive pulmonary disease: a role for heparan sulphate?
Source: Eur Respir J 2007; 30: 80-89
Year: 2007
Serum periostin in patients hospitalized for COPD exacerbations
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD
Source: Eur Respir J 2009; 34: 95-102
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept